subscribeSubscribe
Legend, J&J tap Novartis for commercial production of Carvykti

Legend, J&J tap Novartis for commercial production of Carvykti
FIERCE PHARMA
29 Mar 2024
Share Share
NeoImmuneTech to Present Data on NT-I7 in Combo with CAR-T tisagenlecleucel

NeoImmuneTech to Present Data on NT-I7 in Combo with CAR-T tisagenlecleucel
PRNEWSWIRE
04 Nov 2022
Share Share
Novartis five-year Kymriah data show durable remission and long-term survival

Novartis five-year Kymriah data show durable remission and long-term survival
GLOBENEWSWIRE
12 Jun 2022
Share Share
FDA approves Novartis Kymriah CAR-T cell therapy for r/r follicular lymphoma

FDA approves Novartis Kymriah CAR-T cell therapy for r/r follicular lymphoma
PRNEWSWIRE
27 May 2022
Share Share
Novartis Kymriah® receives EC approval as first CAR-T cell therapy

Novartis Kymriah® receives EC approval as first CAR-T cell therapy
NOVARTIS
04 May 2022
Share Share
Novartis has an idea why Kymriah failed in 2L lymphoma

Novartis has an idea why Kymriah failed in 2L lymphoma
Angus Liu FIERCEPHARMA
15 Dec 2021
Share Share
Blackstone bets on Autolus` CD19 CAR-T in $250M deal

Blackstone bets on Autolus` CD19 CAR-T in $250M deal
M. Gottfried WALLSTREETJOURNAL
09 Nov 2021
Share Share
Priority review for Novartis CAR-T cell therapy Kymriah

Priority review for Novartis CAR-T cell therapy Kymriah
Lucy Parsons PHARMATIMES
26 Oct 2021
Share Share
CRISPR Therapeutics` CAR-T Cancer Therapy Shows Early Promise

CRISPR Therapeutics` CAR-T Cancer Therapy Shows Early Promise
Mark Terry BIOSPACE
13 Oct 2021
Share Share
NeoImmuneTech Begins Dosing in Phase 1b Study of NT-I7 and Kymriah in r/rLBCL

NeoImmuneTech Begins Dosing in Phase 1b Study of NT-I7 and Kymriah in r/rLBCL
BUSINESSWIRE
13 Oct 2021
Share Share